Vitagon 5000iu

Vitagon 5000iu is not an anabolic/androgenic steroid; rather, it is a natural protein hormone that develops in the placenta of a pregnant woman. HCG is produced in the placenta right after implantation. It possesses luteinizing properties because it closely resembles the luteinizing hormone (LH) found in the anterior pituitary gland. During the first 6-8 weeks of pregnancy, the HCG produced sustains the ongoing production of estrogens and gestagens in the corpus luteum. Subsequently, the placenta itself generates these two hormones.

HCG is derived from the urine of pregnant women since it is excreted in its unchanged form from the bloodstream through the kidneys. The commercially available HCG is offered as a dry substance and can be utilized by both men and women. In women, injectable HCG facilitates ovulation as it impacts the final stages of ovum development, thereby encouraging ovulation. It also aids in the production of estrogens and corpus luteum. The fact that exogenous HCG has nearly identical characteristics to luteinizing hormone (LH), which, as stated, is secreted by the pituitary, makes HCG particularly appealing to athletes. In men, LH stimulates Leydig cells in the testes, which in turn triggers the production of androgenic hormones (testosterone). Therefore, athletes often use injectable HCG to boost testosterone production.

Vitagon 5000iu is frequently combined with anabolic/androgenic steroids during or post-treatment. As noted, both oral and injectable steroids create a negative feedback after a certain level and duration of use. This sends a signal to the hypothalamohypophysial testicular axis, as the steroids provide the hypothalamus with incorrect feedback. The hypothalamus subsequently instructs the pituitary to lessen or halt the production of FSH (follicle-stimulating hormone) and LH. Consequently, testosterone levels drop since the testosterone-producing Leydig cells in the testes become insufficiently stimulated due to decreased LH. Since the body generally requires a period to resume testosterone production, athletes may encounter a challenging transition phase after stopping steroid compounds, often leading to significant strength and muscle mass loss. Administering HCG immediately after steroid treatment helps alleviate this circumstance since HCG swiftly and reliably boosts testosterone production in the testes. In cases of testicular atrophy caused by excessive doses and prolonged use, HCG also aids in quickly restoring the testes to their original size. As occasional injections of HCG during steroid use can prevent testicular atrophy, many athletes utilize HCG for two to three weeks in the middle of their steroid cycle. It is often noted that during this period, athletes tend to achieve their best gains in strength and muscle mass. The reasoning for this is evident: on one hand, the athlete's testosterone levels rise sharply due to HCG, while on the other hand, elevated concentrations of anabolic substances are present in the bloodstream due to the steroids. Many bodybuilders, powerlifters, and weightlifters notice a decrease in sexual drive at the end of an extensive workout cycle, particularly before or after a competition, and especially toward the conclusion of steroid treatment. Athletes who have used steroids frequently tend to accept this as a temporary issue. However, those who use steroids year-round may face psychological effects or even risk relationship problems due to this issue and should consider this disadvantage when using HCG regularly. A reduced libido and reduced spermatogenesis due to steroid use can often be effectively treated with HCG.

Most athletes, however, use Vitagon 5000iu at the end of a treatment to prevent a "crash," aiming to transition smoothly back to "natural training." A key condition for this is that steroid intake or dosages should be tapered off gradually and evenly before starting HCG. Although HCG can cause a rapid and significant rise in endogenous plasma testosterone levels, it is not a definitive solution to prevent strength and mass loss following steroid treatment. The athlete will still go through a re-adjustment phase, which has been frequently documented, albeit delayed due to HCG. While HCG encourages endogenous testosterone production, it does not effectively restore the normal hypothalamic/pituitary/testicular axis. The hypothalamus and pituitary remain in a refractory state after extended steroid use, persisting while HCG is administered because the endogenous testosterone produced from exogenous HCG suppresses endogenous LH production. Once HCG is stopped, the athlete still faces a re-adjustment phase. Thus, experienced athletes often take Clomid and Clenbuterol after HCG treatment, or they may commence another steroid cycle immediately. Some individuals use HCG simply to take a break from steroids for a couple of weeks.

Unfortunately, many bodybuilders still believe that HCG aids in hardening their physique while preparing for a competition by facilitating the breakdown of subcutaneous fat, resulting in improved definition and vascularity. However, the HCG product insert clearly states that it has no known impact on fat mobilization, appetite, hunger, or body fat distribution. HCG has not been proven effective as an adjunctive therapy for obesity and does not enhance fat loss beyond what is achieved through caloric restriction.

Athletes are recommended to inject 5000 IU every 5 days. Since testosterone levels, as explained, remain significantly elevated for several days, more frequent HCG injections are unnecessary. The appropriate dosage is at the athlete's discretion and should be based on the length of prior steroid use and the potency of the various steroid compounds. Athletes who have used steroids for over three months or primarily high-androgen steroids such as Androlic, Sustanon 250, Cypionate, and Dianabol (D-bol) should opt for a relatively high dosage. Typically, the effective dosage for athletes ranges from 2000-5000 IU per injection, administered every 5 days. HCG should be limited to a maximum duration of 4 weeks.

If HCG is used by male athletes for extended periods and in high doses, there is a risk that the testes may respond poorly to subsequent HCG administration and the body's natural LH release, potentially leading to permanent inadequate gonadal function. HCG cycles should be limited to approximately 3 weeks per instance, followed by at least a month off between cycles. For instance, HCG could be used for 2 to 3 weeks during the middle of a steroid cycle, and again for 2 to 3 weeks at the end. It has been speculated that prolonged HCG use could permanently suppress endogenous gonadotropin production in the body. This is why short cycles are recommended.

Vitagon 5000iu can occasionally cause side effects similar to those associated with injectable testosterone. Increased testosterone production is often accompanied by elevated estrogen levels, which may lead to gynecomastia. This could manifest as temporary breast growth or exacerbate existing gynecomastia in men. Thus, forward-thinking athletes combine HCG with antiestrogens. Male athletes also report increased frequency of erections and heightened libido. In high doses, HCG can result in acne vulgaris and mineral and water retention. This last point is especially important as water retention from HCG usage can give the muscle appearance a bloated and watery look. Athletes who have previously raised their endogenous testosterone levels through Clomid and are planning to use HCG afterwards may experience significant water retention and prominent feminization symptoms (gynecomastia, increased fat deposits around the hips). This is because higher testosterone levels lead to an increased conversion rate to estrogens. In younger athletes, HCG, much like anabolic steroids, may cause premature closure of epiphyseal growth plates, potentially stunting growth. Mood swings and high blood pressure can also be linked to HCG use. Vitagon 5000iu is also fitting as a "bridge" doping option before competitions subject to doping controls.

The method of administering HCG is also unique. Choriongonadotropin is presented as a white, powdery freeze-dried substance typically used as a compress. Due to the low structural stability of this compress, it may easily disintegrate, which can create the illusion of reduced volume. However, this is inconsequential since there is neither a decrease in effect nor in substance. Each HCG package includes an additional ampule with an injection solution comprising isotonic sodium chloride. After both ampules have been opened in a sterile manner, this liquid is injected into the HCG ampule and mixed with the dried material. The solution is then ready for usage and should be administered intramuscularly. If only part of the mixture is used, any remaining solution should be kept in the refrigerator. While it is unnecessary to refrigerate uncombined HCG, it should be stored away from light and at temperatures below 25°C. HCG is considered a relatively expensive compound.